1. Home
  2. ULY vs JAGX Comparison

ULY vs JAGX Comparison

Compare ULY & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urgent.ly Inc.

ULY

Urgent.ly Inc.

N/A

Current Price

$2.04

Market Cap

4.0M

Sector

N/A

ML Signal

N/A

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

N/A

Current Price

$1.19

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ULY
JAGX
Founded
2013
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
3.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ULY
JAGX
Price
$2.04
$1.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$11.50
$60.00
AVG Volume (30 Days)
68.8K
387.2K
Earning Date
11-12-2025
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$127,932,000.00
$11,785,000.00
Revenue This Year
N/A
$22.41
Revenue Next Year
$18.95
$30.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.45
52 Week Low
$1.74
$1.00
52 Week High
$17.99
$33.25

Technical Indicators

Market Signals
Indicator
ULY
JAGX
Relative Strength Index (RSI) 42.25 41.91
Support Level $1.85 $1.05
Resistance Level $3.13 $1.36
Average True Range (ATR) 0.30 0.15
MACD 0.03 0.03
Stochastic Oscillator 21.01 38.00

Price Performance

Historical Comparison
ULY
JAGX

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: